AG
BSTC

Advisor Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Advisor Group’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Sell
60
-663
-92% -$35.1K ﹤0.01% 4921
2019
Q3 		$39K Sell
723
-11
-1% -$640 ﹤0.01% 3566
2019
Q2 		$44K Buy
734
+356
+94% +$22.4K ﹤0.01% 3470
2019
Q1 		$24K Buy
+378
New +$25K ﹤0.01% 3900

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisor Group's BSTC Position: Q4 2019 in Review

Advisor Group reduced its BioSpecifics Technologies Corp. (BSTC) stake by 92% in Q4 2019, selling an estimated $35.1K and leaving 60 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4921.

Advisor Group first reported a position in BSTC in Q1 2019 and has held it in 4 quarters since. The position peaked at $44K in Q2 2019. 112 funds tracked by Wall St. Rank hold BSTC as of Q4 2019.

  • Advisor Group held 60 shares of BioSpecifics Technologies Corp. worth $3K as of Q4 2019.
  • Advisor Group sold 663 BioSpecifics Technologies Corp. shares in Q4 2019, an estimated $35.1K.
  • BioSpecifics Technologies Corp. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4921 holding.
  • Advisor Group first reported a position in BioSpecifics Technologies Corp. in Q1 2019 and has held it in 4 quarters since.
  • Advisor Group's BioSpecifics Technologies Corp. position peaked at $44K in Q2 2019.
  • 112 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.